Realtime-Estimate
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
7.31 USD | +43.05% | +37.76% | +44.62% |
Kurzporträt
Mitarbeiterzahl: 628
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Richard Adcock
CEO | Chief Executive Officer | 55 | 01.10.20 |
Founder | 71 | 01.12.14 | |
David Sachs
DFI | Director of Finance/CFO | 46 | 01.07.19 |
Leonard Sender
COO | Chief Operating Officer | - | 01.03.20 |
John Lee
CTO | Chief Tech/Sci/R&D Officer | 56 | 01.03.19 |
Sandeep K. Reddy
CTO | Chief Tech/Sci/R&D Officer | - | 01.08.20 |
Hans Klingemann
CTO | Chief Tech/Sci/R&D Officer | 74 | - |
Enrique Dilone
CTO | Chief Tech/Sci/R&D Officer | 57 | 14.08.23 |
Barry Simon
BRD | Director/Board Member | 69 | 01.01.07 |
- | - |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Founder | 71 | 01.12.14 | |
Cheryl L. Cohen
BRD | Director/Board Member | 58 | 01.06.19 |
Wesley Clark
BRD | Director/Board Member | 78 | 24.02.21 |
Director/Board Member | 69 | 01.08.20 | |
Barry Simon
BRD | Director/Board Member | 69 | 01.01.07 |
Michael Blaszyk
BRD | Director/Board Member | 71 | 01.07.15 |
Richard Adcock
CEO | Chief Executive Officer | 55 | 01.10.20 |
John Brennan
BRD | Director/Board Member | 67 | 24.02.21 |
Linda Maxwell
BRD | Director/Board Member | 50 | 29.03.21 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 674 116 078 | 137 028 132 ( 20,33 %) | 163 800 ( 0,0243 %) | 20,33 % |
Unternehmenskontakt
Sektor
Verlauf des Gewinns je Aktie
% 1. Jan. | Kap. | |
---|---|---|
+44.62% | 3.46 Mrd. | |
-2.31% | 103 Mrd. | |
+0.36% | 95.71 Mrd. | |
+1.69% | 22.02 Mrd. | |
-17.01% | 20.9 Mrd. | |
-9.30% | 17.85 Mrd. | |
-41.01% | 16.21 Mrd. | |
-14.88% | 15.52 Mrd. | |
+2.82% | 13.86 Mrd. | |
+33.84% | 12.04 Mrd. |
- Börse
- Aktien
- A2QQ2E Aktie
- Unternehmen ImmunityBio, Inc.